Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisionsThe Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a lifetime ban on participating in the pharmaceutical industry, and they are asking a judge to hold him in contempt.In a motion filed on Tuesday in US district court...
Original Article: The Guardian
1 week ago
FTC and seven states seek contempt ruling against Shkreli over pharma ban
Boycott Vote
Should there be a boycott related to this issue?
Cast Your Boycott Vote
Yes — Support a boycott
0%
(0)
No — Do not boycott
0%
(0)
Community Vote
0 votes
No votes yet — be the first to vote
0 total votes